Changeflow GovPing Healthcare & Life Sciences Protein Degraders Patent Application
Routine Notice Added Draft

Protein Degraders Patent Application

Favicon for changeflow.com USPTO Patent Applications - Organic Chemistry (C07D)
Published
Detected
Email

Summary

The USPTO has published a new patent application, US20260085075A1, related to protein degraders and their uses. The application was filed on August 19, 2025, by inventors Nello Mainolfi, Nan Ji, Yi Zhang, and Matthew M. Weiss.

Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

The United States Patent and Trademark Office (USPTO) has published a new patent application, US20260085075A1, concerning protein degraders and methods for their use in treating protein-mediated disorders. The application, filed on August 19, 2025, by inventors Nello Mainolfi, Nan Ji, Yi Zhang, and Matthew M. Weiss, includes abstract claims for compounds and compositions designed for targeted protein degradation.

This publication represents a new patent application filing and does not impose immediate compliance obligations. However, it signifies potential future intellectual property developments in the field of targeted protein degradation, which may impact research and development strategies for pharmaceutical and biotechnology companies. Companies operating in this space should monitor the progress of this application and related patents.

Archived snapshot

Mar 26, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Applications

PROTEIN DEGRADERS AND USES THEREOF

Application US20260085075A1 Kind: A1 Mar 26, 2026

Inventors

Nello Mainolfi, Nan Ji, Yi Zhang, Matthew M. Weiss

Abstract

The present invention provides compounds, compositions thereof, and methods of using the same for the targeted degradation of proteins, and the treatment of target protein-mediated disorders.

CPC Classifications

C07D 495/14

Filing Date

2025-08-19

Application No.

19304052

View original document →

Named provisions

Abstract

Get daily alerts for USPTO Patent Applications - Organic Chemistry (C07D)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
August 19th, 2025
Instrument
Notice
Legal weight
Non-binding
Stage
Draft
Change scope
Minor
Document ID
US20260085075A1
Docket
19304052

Who this affects

Applies to
Drug manufacturers Pharmaceutical companies
Industry sector
3254 Pharmaceutical Manufacturing 3254.1 Biotechnology
Activity scope
Drug Discovery Intellectual Property Management
Geographic scope
United States US

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Legal
Topics
Intellectual Property Biotechnology

Get alerts for this source

We'll email you when USPTO Patent Applications - Organic Chemistry (C07D) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!